FDA 483 - Imagilin Technology Llc - January 16, 2020
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Imagilin Technology LLC, a manufacturer of dietary supplements, identified significant deficiencies in their manufacturing processes. The firm failed to establish and follow written master manufacturing records for their probiotic products. Additionally, Imagilin Technology LLC did not establish required product specifications for identity, purity, strength, composition, or contamination limits for their finished dietary supplements and their components.
ID · 3513c541-8463-4f69-b8c6-cca2013e475d